ICM
SEAT icon

Invenomic Capital Management’s Vivid Seats SEAT Stock Holding History

Invenomic Capital Management’s Portfolio SEAT Stock Details SEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-64,605
Closed -$3.82M – 189
2025
Q1 		$3.82M Sell
64,605
-15,156
-19% -$1.22M 0.19% 128
2024
Q4 		$7.39M Sell
79,761
-12,425
-13% -$926K 0.35% 91
2024
Q3 		$6.82M Sell
92,186
-18,277
-17% -$1.67M 0.37% 81
2024
Q2 		$12.7M Buy
110,463
+33,503
+44% +$3.64M 0.62% 54
2024
Q1 		$9.22M Buy
76,960
+57,194
+289% +$6.71M 0.49% 71
2023
Q4 		$2.5M Sell
19,766
-14,571
-42% -$2M 0.11% 138
2023
Q3 		$4.41M Buy
34,337
+767
+2% +$113K 0.19% 101
2023
Q2 		$5.32M Buy
33,570
+207
+0.6% +$32.3K 0.27% 82
2023
Q1 		$5.09M Buy
33,363
+5,620
+20% +$879K 0.29% 91
2022
Q4 		$4.05M Buy
+27,743
New +$4.31M 0.27% 98

Other funds holding SEAT

SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
EVC
Emeth Value Capital New Orleans, Louisiana $28.8M AUM 29.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCMF
Private Capital Management (Florida) Naples, Florida $1.14B AUM 34.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $530M AUM 69.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invenomic Capital Management's SEAT Position: Q2 2025 in Review

Invenomic Capital Management sold out of Vivid Seats (SEAT) in Q2 2025, closing a stake of 64,605 shares — an estimated $3.82M sold.

Invenomic Capital Management first reported a position in SEAT in Q4 2022 and held it in 10 quarters. The position peaked at $12.7M in Q2 2024. 100 funds tracked by Wall St. Rank hold SEAT as of Q2 2025.

  • Invenomic Capital Management reported no remaining Vivid Seats position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 64,605 Vivid Seats shares in Q2 2025, an estimated $3.82M.
  • Invenomic Capital Management first reported a position in Vivid Seats in Q4 2022 and held it in 10 quarters.
  • Invenomic Capital Management's Vivid Seats position peaked at $12.7M in Q2 2024.
  • 100 funds tracked by Wall St. Rank held Vivid Seats as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.